Navigation Links
Cellectis' Meganuclease Technology Used to Efficiently Prevent Viral Infection
Date:1/19/2011

PARIS, Jan. 19, 2011 /PRNewswire/ -- Cellectis (Alternext: ALCLS), announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1). The research has just been published online by Molecular Therapy(1) (Mol. Ther. 2011, Jan 11. Epublication ahead of print).  These are the first proof-of-concept data showing that meganucleases can prevent viral infection.

In this article, scientists used HSV-1 specific meganucleases engineered by Cellectis to successfully prevent the infection of human cultured cells by HSV-1. Subsequent analysis of the treated cells using deep sequencing techniques showed that inhibition of HSV-1 infection by the anti-HSV-1 meganucleases was associated with cleavage of viral DNA (or virus clipping). When the virus is clipped at a well-chosen and specific location, this prevents its normal activity as well as its ability to replicate and spread.

"Virus clipping using meganucleases is a new therapeutic approach to tackle persistent viral infection which could have broad applications in medicine," said Pr. Jose Alain Sahel, Director of Institut de la Vision. "We are particularly interested in the potential of meganucleases in the prevention of recurrent infection during corneal transplantation and look forward to continuing our studies in this area."

"The results published in Molecular Therapy are very exciting since they open new fields of research for fighting HSV recurrent infections, a major cause of both acquired and severe loss of vision," added Dr. Marc Labetoulle, M.D., Ph.D. of CNRS.

About HSV-1 infection

HSV-1 infection is highly prevalent globally, with an estimated 70-90% of the adult population carrying the virus. The majority of seropositive individuals are unaware th
'/>"/>

SOURCE Cellectis therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
2. Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
4. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
5. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
6. Cellectis Unveils Its New Corporate Website
7. Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store
8. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
9. Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
10. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
11. Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... DIEGO and BETHESDA, Md. ... are joining together with two institutes from the National ... reliable tools for bringing safer, more effective treatments to ... the National Center for Advancing Translational Sciences (NCATS) and ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 During the ... now known as “The Doctor’s Plague.” In this time period, ... hands. This led, at times, to the death of vulnerable ... today don’t know that they may be unwittingly transmitting herpes ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... 2011 CryoLife, Inc. (NYSE: CRY ), an ... today that it has filed an IDE with ... clinical trials for the purpose of obtaining Pre-Market Approval (PMA) ... surgical procedures or following traumatic injuries. PerClot ...
... 2011 Orexigen ® Therapeutics, Inc. (Nasdaq: ... showed that overweight and obese patients treated with ... 24-hour circadian patterns over one year of treatment. ... monitoring (ABPM) sub-study of the COR-II trial that ...
... OMER ), a biopharmaceutical company committed to ... and disorders of the central nervous system, today announced ... officer, is scheduled to present at the 10th Annual ... this week.  The presentation is scheduled for Tuesday, April ...
Cached Biology Technology:CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 2CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 3CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 4Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 2Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 3Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 4
(Date:7/10/2014)... 10, 2014Women in the West African nation Burkina ... planning option. Sayana Press has the potential to ... the health system and in communities by combining ... Depo-Provera (depot medroxyprogesterone acetate)with the BD Uniject injection ... four African countries expected to begin introducing Sayana ...
(Date:7/9/2014)... Caesarean section have a different intestinal flora than children delivered ... is the case and what it means for the immune ... therefore decided to scrutinise the impact of birth on the ... mouse pups. , The study shows that ... of cells that strengthen the immune system, says Camilla Hartmann ...
(Date:7/9/2014)... hunts in Indiana state parks have helped restore the ... by overabundant populations of white-tailed deer, a Purdue study ... associate professor of forest ecology, found that a 17-year-long ... in state parks has successfully spurred the regrowth of ... browsing deer. , Jenkins said that while hunting ...
Breaking Biology News(10 mins):Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3Mouse study: Natural birth may strengthen the immune system 2Hunting gives deer-damaged forests in state parks a shot at recovery 2
... in the Canadian Rockies are stifling the mating choices ... researchers. , Smaller and less abundant alpine meadows--largely the ... pool, creating a pattern that could lead to the ... Roland, a biological scientist at the University of Alberta ...
... and bitter tastes may reside in the same taste bud ... discovery of a chemical messenger called neuropeptide Y (NPY) in ... is active in the brain and gut, this is the ... taste bud cells. , That finding gives scientists a deeper ...
... which is involved in cellular immune signaling, scientists have succeeded ... This old protein with a new twist may eventually be ... Stat1 is involved in immune responses that are initiated by ... cells of the immune system in response to challenges by ...
Cached Biology News:Expanding forests darken the outlook for butterflies, study shows 2Bitter or sweet? The same taste bud can tell the difference 2Bitter or sweet? The same taste bud can tell the difference 3Engineered molecule amplifies body's immune response 2Engineered molecule amplifies body's immune response 3
...
... T4 DNA Ligase catalyzes the formation ... ATP between double-stranded DNAs with 3' hydroxyl ... DNA Ligase buffer optimizes ligation which can ... nucleic acids are not substrates for this ...
Bovine Renal Artery Smooth Muscle Cells (BRASMC) (>500,000 cells)...
... The Finnpipette BioControl is a ... technology. A complete liquid handling system ... twelve interchangeable tip cone modules. All ... tip cone modules fit one handle. ...
Biology Products: